Read more

May 30, 2021
1 min read
Save

Top in cardiology: Coronary heart disease risk, BP-raising medication trends

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Premature menopause was tied to a higher risk for coronary heart disease, according to researchers. A summary of their findings was the top story in cardiology last week.

Another top story was about an analysis that showed many adults with hypertension receive BP-raising medications, prompting researchers to recommend that clinicians take a closer look at their patients’ prescription and over-the-counter medication use.

Prescription
Source: Adobe Stock

Read these and more top stories in cardiology below:

Premature menopause associated with 40% higher risk for coronary heart disease

Premature menopause was associated with a 40% increased risk for coronary heart disease, and Black women were three times more likely to experience premature menopause than white women, researchers reported. Read more.

Many adults with hypertension take BP-raising medications

Nearly 1 in 5 adults with elevated BP also take a medication that could be raising their BP, according to a presentation at the American College of Cardiology Scientific Session. Read more.

Adopting healthy lifestyle behaviors may reduce dementia risk in those with family history

The adoption of at least three healthy behaviors was associated with reduced risk for dementia among individuals with familial dementia, a speaker reported. Read more.

Ziltivekimab reduces inflammatory biomarkers tied to atherosclerosis

Ziltivekimab, a novel interleukin-6 ligand inhibitor, significantly reduced multiple inflammatory and thrombotic biomarkers associated with atherosclerosis, according to data presented at the American College Cardiology Scientific Session. Read more.

AI-based echo analyses best human analyses for COVID-19 mortality prediction

In patients with COVID-19 who had an echocardiogram, analysis by artificial intelligence better predicted mortality than analysis by experts, according to the results of the WASE-COVID study. Read more.